DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Sanofi (ADR) (NYSE: SNY)

company name or ticker
Company Photos
(Click to zoom)

European ADRs Flat as Pharma Gains Are Outweighed By Mining Losses

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Investors' Love/Hate Relationship with MannKind Corp. Stock

Emotions run high when it comes to this biotech.

Is It Time for GlaxoSmithKline plc to Change Management?

GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?

Isis Pharmaceuticals Reports Phase I Data on Lipid Candidate - Analyst Blog

Why It Makes Sense For Sanofi To Acquire Zoetis

Health Care Sector Update for 03/24/2015: VCEL,ABMD,CTIX

Is This The Biggest Threat to Isis Pharmaceuticals Stock?

Isis Pharmaceuticals has garnered a massive premium based on the potential of its antisense drug pipeline. With numerous companies entering the rare disease field, though, Isis' drugs might face stiff competition. So are investors being overly optimistic?

In Case You Missed It, This Tiny Biotech Is Poised for Explosive Growth

Amicus Therapeutics, Inc. plans to file its drug for Fabry disease with EU and U.S. regulators soon.

3 Biotech Stocks to Buy If the Sector Crashes

Our experts recommend Alnylam Pharmaceuticals, Celgene, and Biogen Idec.
See More Articles...